Tumor necrosis factor alpha is released by monocytes in OKT3 monoclonal antibody immunosuppressive therapy.
Urra
J M
JM
Laboratory of Immunology, Hospital Alarcos, Ciudad Real, Oviedo, Spain.
Peces
R
R
Martinez-Naves
E
E
Gutierrez
V
V
Setién
F
F
López-Larrea
C
C
D002460:Cell Line; D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D005434:Flow Cytometry; D006801:Humans; D008264:Macrophages / Q000187:drug effects / Q000276:immunology; D009000:Monocytes / Q000187:drug effects* / Q000276:immunology; D016853:Muromonab-CD3 / Q000494:pharmacology*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
D016853:Muromonab-CD3; D014409:Tumor Necrosis Factor-alpha